2024-11-17 14:56:00
To further expand the global footprint of its groundbreaking health and wellness applications, Canada-based Myant Corp., a leading provider of advanced healthcare materials, today announced the acquisition of Nanoleq and Osmotex, two leading textile computing companies Based in Switzerland. Zurich has been selected as the headquarters for Myant’s EU and EMEA expansion. These acquisitions will add valuable talent to the company and further consolidate Myant’s leadership position in textile technology. By entering the market and expanding into Europe, Myant is realizing its goal of becoming a global leader in advanced healthcare materials and setting a new standard for connecting people with people and technology.
Nanoleq: a leading Swiss company specializing in smart textiles and biosensor technologies
This strategic acquisition supports Myant’s goal of advancing the future of connected health by integrating Nanoleq’s advanced sensing capabilities into its growing medical device portfolio.
Both companies have a vision to shift the paradigm of healthcare towards prevention and help people by enabling long-term monitoring through textile computer interfaces and clinical data beyond the hospital into the home. Nanoleq’s innovative work in the development of elastic electrical cables, dry electrodes and biosensing technologies is particularly evident in the flagship model Oxa. Oxa allows users to monitor their respiratory function, ECG, heart rate variability (HRV) and stress levels using its state-of-the-art sensor system and receive real-time feedback on their vital signs to improve their physical and mental well-being.
“It is with great enthusiasm that we welcome Nanoleq to the Myant Group,” said Tony Chahine, CEO of Myant. “This acquisition is a critical milestone in our journey to transform healthcare by integrating intelligence into the fabric of everyday life. Health is at the heart of a productive life, and Myant is now ready to further advance the development of innovative personalized medical solutions that enable individuals to proactively monitor their health. The Nanoleq team shares our vision and will support our efforts European and European markets to enter the Middle East will continue to accelerate.”
“Very few companies have succeeded in producing reliable, medically safe, intelligent textiles. Myant’s acquisition of Nanoleq therefore marks an exciting new chapter for us and will help us to significantly scale our activities,” comments Vincent Martinez, CEO at Nanoleq. “The combination of Nanoleq’s expertise in electrically conductive silicones for biosensing With Myant’s medical expertise, this acquisition is a logical step. Both companies agree that our healthcare model is outdated. People need to be empowered to learn about their health before they get sick. All members of our society benefit from improved prevention.
Osmotex: advanced technologies for moisture and fluid management in textiles and medicine
Myant also acquired the technologies of the Swiss deep tech company Osmotex after a joint venture phase. These technologies enable precise control of moisture and particles in individual microchannels as well as in membranes and textiles with billions of such channels or pores.
For textiles and garments, the technology offers an “electronically controlled breathable membrane” that can withstand human sweat rates in the most extreme conditions. This innovation represents a breakthrough for protective clothing and first aid clothing. It acts like a second skin and increases the physiological comfort, performance and safety of the wearer.
In the medical field, Osmotex fabrics will similarly be used as a second skin for optimal wound healing and as next-generation drug delivery systems. Diagnostic applications through the collection, separation and analysis of liquids are also being developed.
“The Osmotex technology is a milestone in the field of moisture and fluid management,” reports Tony Chahine, CEO at Myant. “The technology acts like a second skin and directly influences the physiological and microclimatic conditions of the wearer. Whether in intelligent wound dressings for a rapid healing or in firefighter uniforms to avoid dangerous heat exposure – it removes the limitations of current variants that extract moisture directly from the air, opening up further possibilities, with significant potential for energy savings and reduction of material wear.”
“With Myant, we are now able to maximize the benefits of our technologies,” explains Trond Heldal, CEO of Myant Swiss and former CEO of Osmotex. “We have developed a unique solid-state pump technology based on state-of-the-art materials science and technology “In Myant, we have gained an equally unique partner who covers the value chain from its 17,000 square meter state-of-the-art materials laboratories through manufacturing to integration into a variety of finished products and services.”
About Myant Corp
Myant’s goal is to enable and improve quality of life for everyone. We leverage advances in AI, medicine and advanced materials to promote health, safety, connection and confidence at every stage of life.
Myant is leading a new era of evolution in which AI guardians enhance human capabilities using textile interfaces that function like a connected second skin. Made from groundbreaking modern materials, this second skin blends naturally into our everyday lives and sets new standards for seamless interaction with the digital world.
From birth to old age, AI guardians enrich our daily lives, promote our well-being, keep us safe, redefine how we connect with society, and enable universal access to the best possible care at all times.
In 2024, Myant expanded into the EU with significant growth and brought on world-renowned AI scientist Dr. Xin Gao on board as Chief AI Officer.
For more information, see www.myant.ca.
Information about Nanoleq
Nanoleq is a leading Swiss company for state-of-the-art, flexible and elastic electrical connections, dry electrodes and biosensor technologies. Its flagship product, Oxa, is a smart wearable that tracks respiratory health, ECG, heart rate variability and other physiological markers, providing actionable data on health and well-being.
For more information, see www.nanoleq.com.
Information about Osmotex
Osmotex, a Swiss technology company, has developed and patented innovative technologies for the controlled transport of moisture in micropores, membranes and textiles. The product range includes microfluidic pumps for life sciences, wound care and medical applications as well as air-conditioned clothing for sports. These innovations were developed over several years in close collaboration with leading Swiss universities and research institutes and are protected by a solid patent portfolio.
Consumer Electronic Show (CES) 2025
From January 7-10, 2025, Myant will be at booth 53618 at the Venetian Expo & Convention Center, 201 Sands Ave. in Las Vegas, NV 89169, USA.
1731855979
#Myant #Acquires #Nanoleq #Osmotex #Technologies #Strengthening #Leadership #Advanced #Materials #Textile
What specific benefits do you foresee from Myant’s acquisitions of Nanoleq and Osmotex in the healthcare technology market?
**Interview with Tony Chahine, CEO of Myant Corp.**
**Interviewer:** Thank you for joining us, Tony. Congratulations on the acquisitions of Nanoleq and Osmotex. What motivated Myant to expand its operations into Europe with these investments?
**Tony Chahine:** Thank you! We’re excited about this new chapter. Acquiring Nanoleq and Osmotex aligns perfectly with our vision to transform healthcare through textile technology. By expanding into Europe, particularly from our new headquarters in Zurich, we aim to tap into a rich market of innovation and collaboration. These companies bring invaluable expertise that will help us enhance our health and wellness applications significantly.
**Interviewer:** Can you elaborate on how Nanoleq’s technology will integrate with Myant’s existing portfolio?
**Tony Chahine:** Absolutely. Nanoleq specializes in smart textiles and biosensing technologies, which are crucial for our mission to shift healthcare toward preventive measures. Their flagship product, Oxa, allows users to monitor vital signs in real time. By integrating Nanoleq’s advanced sensing capabilities, we can significantly enhance our portfolio of medical devices, empowering users to take proactive control of their health.
**Interviewer:** You mentioned the importance of preventive healthcare. How do you envision Myant contributing to this shift?
**Tony Chahine:** Our goal is to create connected health solutions that extend beyond traditional healthcare settings. We believe that individuals should have access to their health data to make informed choices. By embedding intelligence into everyday textiles, we can facilitate long-term monitoring right from the comfort of home, potentially reducing the burden on healthcare systems.
**Interviewer:** Turning to Osmotex, how does their technology complement your vision for advanced healthcare materials?
**Tony Chahine:** Osmotex offers pioneering technologies for moisture and fluid management in textiles. Their electronically controlled breathable membranes can have a transformative impact on both medical applications and protective clothing. For instance, we envision these fabrics being used in wound healing and drug delivery systems, ultimately enhancing patient recovery and comfort.
**Interviewer:** What do you believe sets Myant apart in the evolving field of health technology?
**Tony Chahine:** Myant’s unique approach lies in our ability to seamlessly integrate textile interfaces with advanced AI and medical science. This combination allows us to create what we call a “second skin” — a health-monitoring system that is as intuitive as it is effective. Our aim is to not only improve individual health outcomes but also enhance overall quality of life, making health monitoring a natural part of daily life.
**Interviewer:** what message would you like to convey to those looking to understand Myant’s future direction?
**Tony Chahine:** We are committed to leading a new era of health and wellness powered by innovative textile technology. As we continue to expand globally and explore new markets, our focus will always remain on improving the quality of life through proactive health solutions. We encourage everyone to stay connected with us as we redefine the healthcare landscape.
**Interviewer:** Thank you, Tony, for your insights and for the exciting vision you have for Myant. We look forward to seeing how these developments unfold.
**Tony Chahine:** Thank you for having me! I appreciate the opportunity to share our journey.